EUVIMEDEUVIMED entdecken
Crossref

USP8 – EIF2S1 signaling enhances CML cell survival under TKI ‐induced stress

Chethampadi Gopi Mohan iD, Keechilat Pavithran

The FEBS Journal · 2025

DOI: 10.1111/febs.70372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Chethampadi Gopi Mohan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Amrita School of Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India. Hauptthemen laut MEDLINE: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Eukaryotic Initiation Factor-2, Protein Kinase Inhibitors, Ubiquitin Thiolesterase. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CML is primarily driven by the oncogenic BCR‐ABL fusion kinase; however, tyrosine kinase inhibitor (TKI) resistance remains a significant clinical challenge. A study by Zang et al. identified USP8 as a critical mediator of this resistance. USP8, a deubiquitinase, stabilizes the stress‐response regulator EIF2S1 (eIF2α) by removing K48‐linked ubiquitin chains. This stabilization sustains PERK–EIF2S1‐mediated unfolded protein response (UPR) signaling. The UPR suppresses general protein translation while promoting the expression of adaptive stress‐response genes, allowing CML cells to survive TKI‐induced stress. Consequently, targeting the USP8–EIF2S1 axis is proposed as a key therapeutic strategy to overcome resistance and enhance patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myelogenous, Chronic, BCR-ABL PositiveEukaryotic Initiation Factor-2Protein Kinase InhibitorsUbiquitin ThiolesteraseEndopeptidasesHumansSignal TransductionUnfolded Protein ResponseCell SurvivalDrug Resistance, NeoplasmFusion Proteins, bcr-ableIF-2 Kinase

Stichwörter der Autor:innen

TKI resistance drugsUPR signalingchronic myeloid leukemiadeubiquitinating enzymestructure‐based drug designubiquitin‐specific protease family

Substanzen

Eukaryotic Initiation Factor-2Protein Kinase InhibitorsUbiquitin ThiolesteraseEIF2S1 protein, humanFusion Proteins, bcr-ablEndopeptidaseseIF-2 Kinase

Autor:innen und Institutionen

  • Amrita School of Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.
  • Department of Medical Oncology, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.

ORCID-Profile: Chethampadi Gopi Mohan

Zitieren

APA

Mohan, C. G., & Pavithran, K. (2025). USP8 – EIF2S1 signaling enhances CML cell survival under TKI ‐induced stress. The FEBS Journal. https://doi.org/10.1111/febs.70372

Vancouver

Mohan CG, Pavithran K. USP8 – EIF2S1 signaling enhances CML cell survival under TKI ‐induced stress. The FEBS Journal. 2025. doi:10.1111/febs.70372

BibTeX
@article{Mohan2025,
  author = {Mohan, Chethampadi Gopi and Pavithran, Keechilat},
  title = {USP8 – EIF2S1 signaling enhances CML cell survival under TKI ‐induced stress},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.70372}
}
Kostenlos starten →